Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Estrigenix Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Estrigenix Therapeutics

Estrigenix Therapeutics

Angel

Estrigenix Therapeutics: Innovating next-gen therapies for menopausal women's mental health since 2018.

HQ
Milwaukee, WI, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in 2018, Estrigenix Therapeutics is a privately held pharmaceutical company dedicated to developing innovative therapies aimed at improving the mental and physical health of menopausal women. The company's core mission is to leverage applied and original estrogen-based research to create targeted chemistry solutions that significantly alleviate the symptoms associated with menopause. Estrigenix focuses on pioneering next-generation therapeutics to enhance women's health, with an emphasis on mental well-being during menopause.

Estrigenix Therapeutics has attracted notable investors and experts in the field of women's health and pharmaceutical development. The company has made significant strides in its research and development efforts, positioning itself as a leader in the niche market of menopausal health. Through its groundbreaking work, Estrigenix has had a meaningful impact on the quality of life for menopausal women, offering promising new treatments that address both mental and physical symptoms.

Estrigenix Therapeutics - Similar Companies

Evestra logo

Evestra

evestra.com

MenoGeniX logo

MenoGeniX

menogenix.com

Oviva Therapeutics logo

Oviva Therapeutics

ovivatx.com

Fervent Pharmaceuticals logo

Fervent Pharmaceuticals

ferventpharma.com

Zena Therapeutics logo

Zena Therapeutics

Edgemont Pharmaceuticals logo

Edgemont Pharmaceuticals

Courage Therapeutics logo

Courage Therapeutics

Evecxia logo

Evecxia

evecxia.com

Elastrin Therapeutics logo

Elastrin Therapeutics

elastrin.com

Azure Biotech logo

Azure Biotech

azurebiotech.com

Sojournix logo

Sojournix

Chase Therapeutics logo

Chase Therapeutics

Revagenix logo

Revagenix

revagenix.com

Eirion Therapeutics logo

Eirion Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

Estrigenix Therapeutics - Quick Facts

Who are Estrigenix Therapeutics' competitors?

Companies similar to Estrigenix Therapeutics include Evestra, MenoGeniX, Oviva Therapeutics and Fervent Pharmaceuticals.

When was Estrigenix Therapeutics founded?

Estrigenix Therapeutics was founded in 2018.

Where is Estrigenix Therapeutics' headquarters located?

Estrigenix Therapeutics' headquarters is located in Milwaukee, WI, US.

When was Estrigenix Therapeutics' last funding round?

Estrigenix Therapeutics' most recent funding round was for $75k (USD) in May 2023.

How much has Estrigenix Therapeutics raised to-date?

As of May 30, 2023, Estrigenix Therapeutics has raised a total of $75k (USD).

How many employees does Estrigenix Therapeutics have?

Estrigenix Therapeutics has 4 employees as of Feb 4, 2024.

Estrigenix Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified